Drawing for Serial No. 79219055

USPTO serial 79219055

Serial No. 79219055

Reviewed by CopyMark Law Group

Reg. 5477993Status 709
Filing date
Status date
Registration date
May 29, 2018
Examiner
HISER, CHARLES
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79219055?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Alumit

John Alumit ALUMIT IP135 S. Jackson Street, Suite 200Glendale, CA 91205UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sprays, balms, inhalants and sachets, injection based and ointment based pharmaceutical preparations, and medicine composed of raw materials, all for the treatment of cardiovascular and cardiopulmonary disorders, prevention and treatment of disorders of the nervous system, the immune system, the metabolic system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, for use in surgery, for the treatment of ophthalmological and astroenterological disorders, for the treatment of bacteria-based, fungus-based and viral diseases, for the treatment of diabetes, for the treatment of infectious diseases, allergies, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal and psychiatric diseases and disorders, for wound treatment, and for the treatment of sports related injuries in humansSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 19, 2026INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Feb 1, 2026XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Feb 1, 2026XXCRGENERIC MADRID TRANSACTION CREATED—
Aug 13, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 13, 2024C71TCANCELLED SECTION 71—
Jul 6, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 29, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 16, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 12, 2018XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Sep 12, 2018XXCRGENERIC MADRID TRANSACTION CREATED—
Aug 29, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 29, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 13, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 13, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 21, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 30, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 30, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Jan 30, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 30, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 30, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 26, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 25, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 25, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 1, 2017RFNTREFUSAL PROCESSED BY IB—
Nov 13, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 13, 2017RFRRREFUSAL PROCESSED BY MPU—
Nov 3, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 2, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 31, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 25, 2017DOCKASSIGNED TO EXAMINER—
Oct 25, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 24, 2017LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Oct 19, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance